Latest Weight Loss news
GI Safety Profile Similar for Dulaglutide, Semaglutide, Tirzepatide
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Trump Announces Major Price Cut for Ozempic, Wegovy and Similar Drugs
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACS: 2020 to 2024 Saw Jump in Use of GLP-1 Receptor Agonists Before Metabolic, Bariatric Surgery
posted October 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Weight-Loss Treatment Tied to Lower Risk for Obesity-Related Cancers
posted October 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Bariatric Surgery Is Effective Rescue Strategy After GLP-1 Receptor Agonist Failure 
Weight-Loss Surgery Produces Lasting Diabetes Remission 
Obesity Linked to Early-Onset Cancer Risk in Young Adults .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers Related Articles
2018 to 2025 Saw Sharp Rise in Postpartum GLP-1 Receptor Agonist Use 
Very Low-Carb Diet Shows Greater Cardiometabolic Benefits Than Other Diets 
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths Monthly Specialist Briefings
Stay Connected
